Background and Aims: Although ursodeoxycholic acid (UDCA) treatment in primary biliary cholangitis is effective in many patients, there are still many people wh
The coronavirus pandemic has resulted in increased rates of hepatic decompensation, morbidity and mortality in pa-tients suffering from existing liver disease,